A direct association of apoCIII with atherosclerosis was revealed by clinical genetic studies and studies showing that loss-of-function mutations in APOC3 are associated with low TG levels (40) and a reduced incidence of ischemic CVD (41). The gene discussed is APOC3; the disease is atherosclerosis.